JWH-018 binds to both of those the CB1 and CB2 receptors. The consequences of JWH-018 are primarily attributable to the binding and activation of CB1 receptors. In apply, the compound suppresses the release of neurotransmitters during the central anxious procedure, which points out the multitude of